122 related articles for article (PubMed ID: 10850523)
1. Age and gender effects on the pharmacokinetics of gatifloxacin.
LaCreta FP; Kollia GD; Duncan G; Behr D; Grasela DM
Pharmacotherapy; 2000 Jun; 20(6 Pt 2):67S-75S. PubMed ID: 10850523
[TBL] [Abstract][Full Text] [Related]
2. Safety and pharmacokinetics of a single oral dose of gatifloxacin in patients with moderate to severe hepatic impairment.
Grasela DM; Christofalo B; Kollia GD; Duncan G; Noveck R; Manning JA; LaCreta FP
Pharmacotherapy; 2000 Jun; 20(6 Pt 2):87S-94S. PubMed ID: 10850525
[TBL] [Abstract][Full Text] [Related]
3. Interchangeability of 400-mg intravenous and oral gatifloxacin in healthy adults.
LaCreta FP; Kaul S; Kollia GD; Duncan G; Randall DM; Grasela DM
Pharmacotherapy; 2000 Jun; 20(6 Pt 2):59S-66S. PubMed ID: 10850522
[TBL] [Abstract][Full Text] [Related]
4. Effect of multiple-dose gatifloxacin or ciprofloxacin on glucose homeostasis and insulin production in patients with noninsulin-dependent diabetes mellitus maintained with diet and exercise.
Gajjar DA; LaCreta FP; Kollia GD; Stolz RR; Berger S; Smith WB; Swingle M; Grasela DM
Pharmacotherapy; 2000 Jun; 20(6 Pt 2):76S-86S. PubMed ID: 10850524
[TBL] [Abstract][Full Text] [Related]
5. A dose-escalation study of the safety, tolerability, and pharmacokinetics of intravenous gatifloxacin in healthy adult men.
Gajjar DA; LaCreta FP; Uderman HD; Kollia GD; Duncan G; Birkhofer MJ; Grasela DM
Pharmacotherapy; 2000 Jun; 20(6 Pt 2):49S-58S. PubMed ID: 10850521
[TBL] [Abstract][Full Text] [Related]
6. Gatifloxacin pharmacokinetics in healthy men and women.
Zhang X; Overholser BR; Kays MB; Sowinski KM
J Clin Pharmacol; 2006 Oct; 46(10):1154-62. PubMed ID: 16988204
[TBL] [Abstract][Full Text] [Related]
7. Effect of ensure on the oral bioavailability of gatifloxacin in healthy volunteers.
Kays MB; Overholser BR; Lagvankar S; Goldman M; Sowinski KM
Pharmacotherapy; 2005 Nov; 25(11):1530-5. PubMed ID: 16232015
[TBL] [Abstract][Full Text] [Related]
8. The influence of age and gender on the pharmacokinetics of moxifloxacin.
Sullivan JT; Lettieri JT; Liu P; Heller AH
Clin Pharmacokinet; 2001; 40 Suppl 1():11-8. PubMed ID: 11352437
[TBL] [Abstract][Full Text] [Related]
9. Ocular penetration and pharmacokinetics of topical gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions after keratoplasty.
Holland EJ; Lane SS; Kim T; Raizman M; Dunn S
Cornea; 2008 Apr; 27(3):314-9. PubMed ID: 18362660
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of gatifloxacin pharmacokinetics and pharmacodynamics in severely ill adults in a medical Intensive Care Unit.
Fish DN
Int J Antimicrob Agents; 2007 Jun; 29(6):715-23. PubMed ID: 17433631
[TBL] [Abstract][Full Text] [Related]
11. Single and Multiple Ascending-dose Studies of Oral Delafloxacin: Effects of Food, Sex, and Age.
Hoover R; Hunt T; Benedict M; Paulson SK; Lawrence L; Cammarata S; Sun E
Clin Ther; 2016 Jan; 38(1):39-52. PubMed ID: 26581327
[TBL] [Abstract][Full Text] [Related]
12. Bioavailability of gatifloxacin by gastric tube administration with and without concomitant enteral feeding in critically ill patients.
Kanji S; McKinnon PS; Barletta JF; Kruse JA; Devlin JW
Crit Care Med; 2003 May; 31(5):1347-52. PubMed ID: 12771601
[TBL] [Abstract][Full Text] [Related]
13. Effects of gatifloxacin and levofloxacin on rates of hypoglycemia and hyperglycemia among elderly hospitalized patients.
Lodise T; Graves J; Miller C; Mohr JF; Lomaestro B; Smith RP
Pharmacotherapy; 2007 Nov; 27(11):1498-505. PubMed ID: 17963459
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of gatifloxacin after a single oral dose in healthy young adult subjects and adult patients with chronic bronchitis, with a comparison of drug concentrations obtained by bronchoscopic microsampling and bronchoalveolar lavage.
Kikuchi J; Yamazaki K; Kikuchi E; Ishizaka A; Nishimura M
Clin Ther; 2007 Jan; 29(1):123-30. PubMed ID: 17379052
[TBL] [Abstract][Full Text] [Related]
15. Effect of age and sex on the pharmacokinetics and safety of avibactam in healthy volunteers.
Tarral A; Merdjan H
Clin Ther; 2015 Apr; 37(4):877-86. PubMed ID: 25769615
[TBL] [Abstract][Full Text] [Related]
16. The effects of age and gender on the single dose pharmacokinetics of avitriptan administered to healthy volunteers.
Marathe PH; Greene DS; Kollia GD; Barbhaiya RH
J Clin Pharmacol; 1997 Oct; 37(10):937-45. PubMed ID: 9505985
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of sparfloxacin in patients with renal impairment.
Dorr MB; Johnson RD; Jensen B; Magner D; Marbury T; Talbot GH
Clin Ther; 1999 Jul; 21(7):1202-15. PubMed ID: 10463518
[TBL] [Abstract][Full Text] [Related]
18. Absence of age and gender effects on the pharmacokinetics of a single 500-milligram oral dose of levofloxacin in healthy subjects.
Chien SC; Chow AT; Natarajan J; Williams RR; Wong FA; Rogge MC; Nayak RK
Antimicrob Agents Chemother; 1997 Jul; 41(7):1562-5. PubMed ID: 9210685
[TBL] [Abstract][Full Text] [Related]
19. Effect of age and gender on the pharmacokinetics of grepafloxacin.
Efthymiopoulos C; Bramer SL; Maroli A
Clin Pharmacokinet; 1997; 33 Suppl 1():9-17. PubMed ID: 9433651
[TBL] [Abstract][Full Text] [Related]
20. Effect of gender and age on the relative bioavailability of doravirine: results of a Phase I trial in healthy subjects.
Behm MO; Yee KL; Fan L; Fackler P
Antivir Ther; 2017; 22(4):337-344. PubMed ID: 28206979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
